Dimedi - Company finances
|
EUR
|
2019
From: 2019-02-25
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 0 | 37,106 | 57,793 | 83,163 | 89,863 | 125,039 | 122,350 |
| Profit before tax | - | - | - | - | - | - | - |
| Net profit | 0 | 11,141 | 12,583 | 3,883 | 38,487 | 26,762 | 4,038 |
| Equity | 2,500 | 13,641 | 26,224 | 30,107 | 56,421 | 83,184 | 87,222 |
| Liabilities | 0 | 18,676 | 19,168 | 24,425 | 23,049 | 25,844 | 18,271 |
| Non-current assets | 0 | 0 | 0 | 0 | 12,458 | 10,291 | 10,291 |
| Current assets | 2,500 | 32,317 | 45,392 | 54,532 | 67,012 | 98,737 | 95,202 |
| Total assets | 2,500 | 32,317 | 45,392 | 54,532 | 79,470 | 109,028 | 105,493 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 19,104 | 23,498 | 23,800 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | - | +55.8% | +43.9% | +8.1% | +39.1% | -2.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 34.5% | 27.7% | 7.1% | 48.4% | 24.5% | 3.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 81.7% | 48.0% | 12.9% | 68.2% | 32.2% | 4.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 30.0% | 21.8% | 4.7% | 42.8% | 21.4% | 3.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 1.4 | 0.7 | 0.8 | 0.4 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 16,492 | 57,793 | 83,163 | 89,863 | 125,039 | 122,350 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dimedi - Social security debts
The amount of overdue SODRA debt for the company Dimedi as of the last working day is: 1 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-15 | 0.73 |
| 2026-08-26 | 2026-09-02 | 0.73 |
| 2026-08-23 | 2026-08-23 | 246.73 |
| 2026-08-19 | 2026-08-19 | 246.73 |
| 2026-07-26 | 2026-07-27 | 3.00 |
| 2026-07-23 | 2026-07-25 | 4.32 |
| 2026-07-19 | 2026-07-22 | 3.00 |
| 2026-07-16 | 2026-07-17 | 3.00 |
| 2026-06-16 | 2026-06-24 | 247.37 |
| 2026-06-11 | 2026-06-15 | 0.64 |
| 2026-05-20 | 2026-06-08 | 0.64 |
| 2026-05-17 | 2026-05-19 | 247.37 |
| 2026-05-03 | 2026-05-14 | 0.64 |
| 2026-04-24 | 2026-04-29 | 0.64 |
| 2026-02-18 | 2026-02-25 | 249.09 |
| 2026-01-22 | 2026-02-17 | 2.36 |
| 2026-01-16 | 2026-01-21 | 2.13 |
| 2026-01-01 | 2026-01-11 | 2.13 |
| 2025-11-20 | 2025-12-30 | 2.13 |
| 2025-11-18 | 2025-11-19 | 225.47 |
| 2025-10-23 | 2025-11-17 | 2.13 |
| 2025-10-16 | 2025-10-22 | 1.60 |
| 2025-09-22 | 2025-10-14 | 1.60 |
| 2025-09-16 | 2025-09-21 | 224.94 |
| 2025-09-07 | 2025-09-15 | 1.60 |
| 2025-08-31 | 2025-09-03 | 1.60 |
| 2025-08-28 | 2025-08-29 | 224.94 |
| 2025-08-20 | 2025-08-27 | 1.60 |
| 2025-08-19 | 2025-08-19 | 224.94 |
| 2025-07-24 | 2025-08-18 | 1.60 |
| 2025-07-16 | 2025-07-23 | 0.70 |
| 2025-06-20 | 2025-07-14 | 0.70 |
| 2025-06-17 | 2025-06-19 | 224.04 |
| 2025-06-11 | 2025-06-16 | 0.70 |
| 2025-06-08 | 2025-06-09 | 0.70 |
| 2025-05-19 | 2025-06-04 | 0.70 |
| 2025-05-16 | 2025-05-18 | 224.04 |
| 2025-05-04 | 2025-05-15 | 0.70 |
| 2025-04-24 | 2025-04-29 | 0.70 |
| 2025-04-16 | 2025-04-21 | 223.34 |
| 2025-02-10 | 2025-02-10 | 200.58 |
| 2025-01-22 | 2025-01-27 | 200.58 |
| 2025-01-16 | 2025-01-21 | 200.48 |
| 2025-01-02 | 2025-01-15 | 0.54 |
| 2024-12-22 | 2024-12-31 | 0.54 |
| 2024-10-24 | 2024-12-20 | 0.54 |
| 2024-10-16 | 2024-10-23 | 0.25 |
| 2024-09-17 | 2024-10-13 | 0.25 |
| 2024-07-24 | 2024-09-15 | 0.25 |
| 2024-07-17 | 2024-07-23 | 0.01 |
| 2024-07-16 | 2024-07-16 | 199.95 |
| 2024-06-18 | 2024-07-15 | 0.01 |
| 2024-05-16 | 2024-06-03 | 0.01 |
| 2024-04-23 | 2024-05-12 | 0.01 |
| 2024-04-16 | 2024-04-18 | 199.77 |
| 2022-12-16 | 2022-12-18 | 157.08 |
| 2022-04-28 | 2022-05-08 | 11.20 |
| 2022-04-19 | 2022-04-27 | 11.11 |
| 2022-03-16 | 2022-04-05 | 13.12 |
| 2022-02-17 | 2022-03-14 | 0.02 |
| 2022-01-31 | 2022-02-09 | 0.02 |
| 2021-12-16 | 2022-01-16 | 0.71 |
| 2021-11-16 | 2021-12-09 | 0.30 |
| 2021-10-18 | 2021-11-15 | 0.24 |
| 2021-09-16 | 2021-10-14 | 0.18 |
Dimedi - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-30 | 2026-07-07 | 0.03 |
| 2026-06-19 | 2026-06-29 | 0.3 |
| 2026-05-06 | 2026-05-07 | 1.3 |
| 2026-04-30 | 2026-05-05 | 0.24 |
| 2026-04-22 | 2026-04-23 | 0.24 |
| 2026-04-17 | 2026-04-21 | 1.24 |
| 2026-03-29 | 2026-04-16 | 0.24 |
| 2026-03-20 | 2026-03-22 | 0.24 |
| 2026-03-08 | 2026-03-08 | 0.24 |
| 2026-03-02 | 2026-03-07 | 37.62 |
| 2026-02-21 | 2026-03-01 | 37.19 |
| 2026-02-13 | 2026-02-20 | 44.19 |
| 2026-02-03 | 2026-02-12 | 0.24 |
| 2026-01-01 | 2026-01-27 | 0.22 |
| 2025-11-28 | 2025-12-25 | 0.27 |
| 2025-11-02 | 2025-11-21 | 0.27 |
| 2025-09-28 | 2025-10-26 | 0.72 |
| 2025-08-28 | 2025-09-23 | 0.72 |
| 2025-07-31 | 2025-08-24 | 0.72 |
| 2025-07-28 | 2025-07-30 | 0.77 |
| 2025-06-28 | 2025-07-20 | 0.77 |
| 2025-06-19 | 2025-06-23 | 0.77 |
| 2025-06-02 | 2025-06-02 | 0.77 |
| 2025-04-30 | 2025-05-24 | 0.31 |
| 2025-04-28 | 2025-04-29 | 0.36 |
| 2025-03-28 | 2025-04-24 | 0.36 |
| 2025-02-28 | 2025-03-24 | 0.36 |
| 2024-12-18 | 2024-12-21 | 1.52 |
| 2024-12-17 | 2024-12-17 | 66.06 |
| 2024-12-04 | 2024-12-16 | 0.95 |
| 2024-12-03 | 2024-12-03 | 706.04 |
| 2024-11-28 | 2024-12-02 | 705.09 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dimedi, UAB (code 305048532) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In 2025, revenue was €122.3K and net profit €4.0K, resulting in a 3.3% profit margin. Revenue decreased by 2.1% year on year, but remained 36.1% above the 2023 level of €89.9K, showing solid two-year top-line growth. Profitability weakened over the same period, with net profit declining from €38.5K in 2023 to €26.8K in 2024 and then to €4.0K in 2025. Total assets were €105.5K at the end of 2025, compared with equity of €87.2K and liabilities of €18.3K. The equity ratio stood at 82.7% and debt-to-equity at 0.21, indicating a strong capital structure. Asset turnover was 1.16x, while ROE was 4.6% and ROA 3.8%. Revenue per employee was €122.3K and profit per employee €4.0K.